HER2 Amplified Active Not Recruiting Phase 2 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0069123 (HER2 Amplified)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02091960A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast CancerTreatment